Titre : | Golodirsen : LiverTox: Clinical and Research Information on Drug-Induced Liver Injury |
Auteurs : | Collectif |
Type de document : | Article |
Editeur : | Bethesda - Maryland [USA] : National Institute of Diabetes and Digestive and Kidney Diseases, 02/2020 |
Langues: | Anglais |
Mots-clés : | article de type review ; dystrophie musculaire de Duchenne ; golodirsen ; médicament ; oligonucléotide antisens |
Résumé : |
[Updated 2020 Feb 27].
Golodirsen is synthetic antisense oligonucleotide designed to cause skipping of abnormal exons in the synthesis of the dystrophin gene and that is used to treat Duchenne muscular dystrophy. Golodirsen has not been reported to cause ALT elevations during therapy and has not been linked to instances of acute liver injury with symptoms and jaundice. |
Lien associé : | Texte complet disponible sur le site Bookshelf NCBI |
Pubmed / DOI : | Pubmed : 32223119 |
N° Profil MNM : | 2020041 |
En ligne : | http://www.ncbi.nlm.nih.gov/pubmed/32223119 |